Behind the Science: From Messy Bench to Hematology Research Breakthrough

Andres Sirulnik, M.D., Ph.D., Senior Vice President and Hematology Clinical Development Unit Head, speaks to our commitment to advancing research in hematological conditions. By leveraging gene therapy and innovative research approaches, our diverse team is developing potentially transformative treatments that can change lives. Watch to learn more about Regeneron’s efforts in hematology research.